| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |